These highlights do not include all the information needed to use SPRAVATO ® safely and effectively. See full prescribing information for SPRAVATO ®. SPRAVATO ® (esketamine) nasal spray, CIII Initial U.S. Approval: 1970 (ketamine)
The Essentials on Esketamine for Treatment-Resistant Depression – Consult QD
Spravato Treatment Center | Esketamine Therapy - Infinity Centers
Nasal esketamine works better than alternative for treatment-resistant depression, study finds
Food and Drug Administration approval: Form of ketamine, also known as "Special K," approved for depression treatment - CBS News
First Esketamine nasal spray session in the UK private sector - Dyad Medical
Esketamine nasal spray for depression | Psychosomatische Medizin und Psychotherapie
Study: Esketamine tops quetiapine in treatment-resistant depression
Spravato (Esketamine) for Treatment Resistant Depression - An FDA Approved "Breakthrough Therapy" - Inspire Malibu %
UAB studying new antidepressant based on party drug - al.com